Collaborate against Corona with Intensive Care Data
- Funded by Netherlands Organisation for Health Research and Development (ZonMW)
- Total publications:0 publications
Grant number: 1.043E+13
Grant search
Key facts
Disease
COVID-19Start & end year
20202022Known Financial Commitments (USD)
$393,348.88Funder
Netherlands Organisation for Health Research and Development (ZonMW)Principal Investigator
Dr. PWG ElbersResearch Location
NetherlandsLead Research Institution
Amsterdam UMC - locatie VUmcResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Supportive care, processes of care and management
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Project description Treatment in intensive care appears to be necessary for many COVID-19 patients. It is of great importance to gain more insight into the disease course of intensive care patients with COVID-19 and the factors that influence it. This can give direction to the treatment of future patients, help in the choice of who should and should not be treated in intensive care and contribute to future capacity planning. Research The project investigates which combination of treatments and properties of which individual intensive care patients with COVID-19 leads to the best outcomes. This is done by means of machine learning, an important form of artificial intelligence, which is applied to large amounts of data from intensive care patients with COVID-19 from some 50 collaborating hospitals. The project is supported by the Dutch Intensive Care Association and the National Intensive Care Evaluation Foundation.